Over the past 10 years, genetic variants in SMAD6 were demonstrated to impinge on the risk of human genetic disorders3–13 such as cardiovascular diseases, including congenital heart defects (CHD), craniosynostosis (CRS) and radioulnar synostosis (RUS). This evidence concerns the gene SMAD6 and congenital heart disease.